226 related articles for article (PubMed ID: 15491815)
21. Porous nanoparticles in drug delivery systems.
Arayne MS; Sultana N
Pak J Pharm Sci; 2006 Apr; 19(2):158-69. PubMed ID: 16751130
[TBL] [Abstract][Full Text] [Related]
22. Long-circulating polymeric nanoparticles bearing a combinatorial coating of PEG and water-soluble chitosan.
Sheng Y; Liu C; Yuan Y; Tao X; Yang F; Shan X; Zhou H; Xu F
Biomaterials; 2009 Apr; 30(12):2340-8. PubMed ID: 19150737
[TBL] [Abstract][Full Text] [Related]
23. Poly(alkylcyanoacrylate) colloidal particles as vehicles for antitumour drug delivery: a comparative study.
Arias JL; Ruiz MA; López-Viota M; Delgado AV
Colloids Surf B Biointerfaces; 2008 Mar; 62(1):64-70. PubMed ID: 17961994
[TBL] [Abstract][Full Text] [Related]
24. The Effect of Polymeric Nanoparticles on Biocompatibility of Carrier Red Blood Cells.
Pan D; Vargas-Morales O; Zern B; Anselmo AC; Gupta V; Zakrewsky M; Mitragotri S; Muzykantov V
PLoS One; 2016; 11(3):e0152074. PubMed ID: 27003833
[TBL] [Abstract][Full Text] [Related]
25. Modularity of RBC hitchhiking with polymeric nanoparticles: testing the limits of non-covalent adsorption.
Lenders V; Escudero R; Koutsoumpou X; Armengol Álvarez L; Rozenski J; Soenen SJ; Zhao Z; Mitragotri S; Baatsen P; Allegaert K; Toelen J; Manshian BB
J Nanobiotechnology; 2022 Jul; 20(1):333. PubMed ID: 35842697
[TBL] [Abstract][Full Text] [Related]
26. Expansile nanoparticles: synthesis, characterization, and in vivo efficacy of an acid-responsive polymeric drug delivery system.
Griset AP; Walpole J; Liu R; Gaffey A; Colson YL; Grinstaff MW
J Am Chem Soc; 2009 Feb; 131(7):2469-71. PubMed ID: 19182897
[TBL] [Abstract][Full Text] [Related]
27. Influence of particle size on transport of methotrexate across blood brain barrier by polysorbate 80-coated polybutylcyanoacrylate nanoparticles.
Gao K; Jiang X
Int J Pharm; 2006 Mar; 310(1-2):213-9. PubMed ID: 16426779
[TBL] [Abstract][Full Text] [Related]
28. Red blood cell-hitchhiking chitosan nanoparticles for prolonged blood circulation time of vitamin K
Wang Y; Zhou C; Ding Y; Liu M; Tai Z; Jin Q; Yang Y; Li Z; Yang M; Gong W; Gao C
Int J Pharm; 2021 Jan; 592():120084. PubMed ID: 33188893
[TBL] [Abstract][Full Text] [Related]
29. Surface-modified loaded human red blood cells for targeting and delivery of drugs.
Sternberg N; Georgieva R; Duft K; Bäumler H
J Microencapsul; 2012; 29(1):9-20. PubMed ID: 22034952
[TBL] [Abstract][Full Text] [Related]
30. Adsorption kinetics of plasma proteins on solid lipid nanoparticles for drug targeting.
Göppert TM; Müller RH
Int J Pharm; 2005 Sep; 302(1-2):172-86. PubMed ID: 16098695
[TBL] [Abstract][Full Text] [Related]
31. Optimization of magnetic nanoparticles for engineering erythrocytes as theranostic agents.
Slavu LM; Antonelli A; Scarpa ES; Abdalla P; Wilhelm C; Silvestri N; Pellegrino T; Scheffler K; Magnani M; Rinaldi R; Di Corato R
Biomater Sci; 2023 May; 11(9):3252-3268. PubMed ID: 36939172
[TBL] [Abstract][Full Text] [Related]
32. Identification of peptide ligands facilitating nanoparticle attachment to erythrocytes.
Hall SS; Mitragotri S; Daugherty PS
Biotechnol Prog; 2007; 23(3):749-54. PubMed ID: 17469847
[TBL] [Abstract][Full Text] [Related]
33. Preformed albumin corona, a protective coating for nanoparticles based drug delivery system.
Peng Q; Zhang S; Yang Q; Zhang T; Wei XQ; Jiang L; Zhang CL; Chen QM; Zhang ZR; Lin YF
Biomaterials; 2013 Nov; 34(33):8521-30. PubMed ID: 23932500
[TBL] [Abstract][Full Text] [Related]
34. [Preparation of solid lipid nanoparticles loaded with all-trans retinoic acid and their evaluation in vitro and in vivo].
Hu LD; Tang X; Cui FD
Yao Xue Xue Bao; 2005 Jan; 40(1):71-5. PubMed ID: 15881775
[TBL] [Abstract][Full Text] [Related]
35. Nanoparticles for drug delivery to the lungs.
Sung JC; Pulliam BL; Edwards DA
Trends Biotechnol; 2007 Dec; 25(12):563-70. PubMed ID: 17997181
[TBL] [Abstract][Full Text] [Related]
36. Slow release properties and liver-targeting characteristics of methotrexate erythrocyte carriers.
Yuan SH; Ge WH; Huo J; Wang XH
Fundam Clin Pharmacol; 2009 Apr; 23(2):189-96. PubMed ID: 19298236
[TBL] [Abstract][Full Text] [Related]
37. Nanoparticle Properties Modulate Their Attachment and Effect on Carrier Red Blood Cells.
Pan DC; Myerson JW; Brenner JS; Patel PN; Anselmo AC; Mitragotri S; Muzykantov V
Sci Rep; 2018 Jan; 8(1):1615. PubMed ID: 29371620
[TBL] [Abstract][Full Text] [Related]
38. Biodistribution of fluoresceinated dextran using novel nanoparticles evading reticuloendothelial system.
Gaur U; Sahoo SK; De TK; Ghosh PC; Maitra A; Ghosh PK
Int J Pharm; 2000 Jul; 202(1-2):1-10. PubMed ID: 10915921
[TBL] [Abstract][Full Text] [Related]
39. Oridonin-loaded poly(epsilon-caprolactone)-poly(ethylene oxide)-poly(epsilon-caprolactone) copolymer nanoparticles: preparation, characterization, and antitumor activity on mice with transplanted hepatoma.
Feng N; Wu P; Li Q; Mei Y; Shi S; Yu J; Xu J; Liu Y; Wang Y
J Drug Target; 2008 Jul; 16(6):479-85. PubMed ID: 18604660
[TBL] [Abstract][Full Text] [Related]
40. Red blood cells: Supercarriers for drugs, biologicals, and nanoparticles and inspiration for advanced delivery systems.
Villa CH; Anselmo AC; Mitragotri S; Muzykantov V
Adv Drug Deliv Rev; 2016 Nov; 106(Pt A):88-103. PubMed ID: 26941164
[TBL] [Abstract][Full Text] [Related]
[Previous] [Next] [New Search]
